Skip to main content
. 2022 Mar 31;19(1):84–95. doi: 10.14245/ns.2143180.590

Table 1.

Tumor characteristics

Variable Overall (n=351) Hardware failure
p-value
No (n=328) Yes (n=23)
Tumor type 0.829
Cancer of unknown primary site 6 (1.7) 6 (1.8) 0 (0)
Other (soft tissue sarcoma, germ cell tumor, ovary, adrenal) 34 (9.7) 30 (9.1) 4 (17)
Stomach 2 (0.6) 2 (0.6) 0 (0)
Skin (melanoma, basalioma) 9 (2.6) 8 (2.4) 1 (4.3)
Lung 27 (7.7) 26 (7.9) 1 (4.3)
Lymphoma 5 (1.4) 5 (1.5) 0 (0)
Multiple myeloma 27 (7.7) 25 (7.6) 2 (8.7)
Breast 86 (25.0) 80 (24.0) 6 (26.0)
Bladder 2 (0.6) 2 (0.6) 0 (0)
Osteosarcoma 3 (0.9) 3 (0.9) 0 (0)
Liver 3 (0.9) 2 (0.6) 1 (4.3)
Plasmacytoma 8 (2.3) 8 (2.4) 0 (0)
Kidney 79 (23) 73 (22.0) 6 (26.0)
Prostate 16 (4.6) 16 (4.9) 0 (0)
Corpus uteri 8 (2.3) 8 (2.4) 0 (0)
Colon 9 (2.6) 9 (2.7) 0 (0)
Chondrosarcoma 6 (1.7) 5 (1.5) 1 (4.3)
Chordoma 9 (2.6) 8 (2.4) 1 (4.3)
Cervix uteri 9 (2.6) 9 (2.7) 0 (0)
Thyroid 3 (0.9) 3 (0.9) 0 (0)
SINS region 0.587
Junctional 156 (44.0) 143 (44.0) 13 (57.0)
Mobile spine 90 (26.0) 85 (26.0) 5 (22.0)
Rigid 13 (3.7) 13 (4.0) 0 (0)
Semirigid 92 (26.0) 87 (27) 5 (22.0)
No. of affected vertebrae 0.493
1 277 (79.0) 259 (79.0) 18 (78.0)
2 41 (12.0) 38 (12.0) 3 (13.0)
3 27 (7.7) 25 (7.6) 2 (8.7)
4 4 (1.1) 4 (1.2) 0 (0)
5 2 (0.6) 2 (0.6) 0 (0)
Spine metastasis number 0.959
Multiple 60 (17) 56 (17) 4 (17)
Several (3 or less) 103 (29) 97 (30) 6 (26)
Solitary 188 (54) 175 (53) 13 (57)
Preoperative radiotherapy 21 (6.0) 20 (6.1) 1 (4.3) > 0.999
Preoperative bone-modifying agent therapy 69 (20.0) 67 (20.0) 2 (8.7) 0.184

Values are presented as number (%).

SINS, spinal instability neoplastic score.

Approximative (Monte Carlo) Pearson chi-square test.